Published January 1, 2018
| Version v1
Journal article
Open
Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer
Creators
- 1. Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey
- 2. Hacettepe Univ, Canc Inst, Dept Basic Oncol, Ankara, Turkey
- 3. Aalborg Univ, Fac Sci & Engn, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark
- 4. Gazi Univ, Fac Med, Dept Pathol, Ankara, Turkey
- 5. Ankara Univ, Fac Med, Dept Internal Med, Ankara, Turkey
- 6. Hacettepe Univ, Fac Med, Dept Anat, Ankara, Turkey
Description
Purpose: The aim of this study is to test folate-conjugated cyclodextrin nanoparticles (FCD-1 and FCD-2) as a vehicle for reducing toxicity and increasing the antitumor efficacy of paclitaxel especially for metastatic breast cancer.
Files
bib-3d261f30-df5a-40b2-a33a-4313b0ca5549.txt
Files
(328 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:8f009e32f29ad90e53c9237b088d06cb
|
328 Bytes | Preview Download |